ISRG Stock Earnings Estimates Boosted by Erste Group Bank

Key Points

• Erste Group Bank raised Intuitive Surgical’s FY2027 EPS estimate to $10.09 from $10.06, compared with the current-year consensus estimate of $8.87.
• Intuitive Surgical’s latest quarterly results exceeded expectations, with EPS of $2.80 versus $2.48 expected and revenue of $2.89 billion, up 18.4% year over year.
• Analyst sentiment remains favorable, with a “Moderate Buy” consensus and an average price target of $501.98, although BTIG recently cut its target to $454 from $469 and insiders have continued selling shares.

Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) - Equities research analysts at Erste Group Bank upped their FY2027 earnings per share estimates for shares of Intuitive Surgical in a research report issued to clients and investors on Thursday, October 8th. Erste Group Bank analyst H. Engel now anticipates that the medical equipment provider will post earnings of $10.09 per share for the year, up from their previous forecast of $10.06. The consensus estimate for Intuitive Surgical's current full-year earnings is $8.87 per share.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.48 by $0.32. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. The company had revenue of $2.89 billion for the quarter, compared to analyst estimates of $2.83 billion. During the same period in the prior year, the firm earned $1.81 earnings per share. The business's revenue for the quarter was up 18.4% compared to the same quarter last year.

ISRG has been the topic of a number of other reports. Sanford C. Bernstein reiterated an "outperform" rating on shares of Intuitive Surgical in a report on Wednesday, August 12th. KeyCorp reissued an "overweight" rating on shares of Intuitive Surgical in a research report on Wednesday, August 12th. Weiss Ratings restated a "hold (c)" rating on shares of Intuitive Surgical in a research note on Friday, August 14th. Piper Sandler reaffirmed an "overweight" rating on shares of Intuitive Surgical in a research report on Friday, August 21st. Finally, BMO Capital Markets reaffirmed an "outperform" rating on shares of Intuitive Surgical in a research report on Monday, July 20th. One investment analyst has rated the stock with a Strong Buy rating, twenty-one have issued a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, Intuitive Surgical presently has an average rating of "Moderate Buy" and an average price target of $501.98.

Intuitive Surgical Stock Performance

Shares of ISRG stock opened at $427.64 on Tuesday. The stock has a market capitalization of $151.08 billion, a P/E ratio of 48.99, a price-to-earnings-growth ratio of 3.20 and a beta of 1.46. The company has a 50 day moving average price of $387.41 and a 200 day moving average price of $410.47. Intuitive Surgical has a fifty-two week low of $328.57 and a fifty-two week high of $603.88.

Insider Buying and Selling at Intuitive Surgical

In related news, EVP Mark Brosius sold 77 shares of the company's stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $375.57, for a total transaction of $28,918.89. Following the sale, the executive vice president directly owned 881 shares in the company, valued at approximately $330,877.17. This represents a 8.04% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gary Guthart sold 10,000 shares of the firm's stock in a transaction that occurred on Tuesday, August 11th. The shares were sold at an average price of $400.00, for a total transaction of $4,000,000.00. Following the completion of the sale, the director directly owned 1,245,679 shares in the company, valued at approximately $498,271,600. This trade represents a 0.80% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders sold 12,370 shares of company stock valued at $4,891,989. 0.60% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Intuitive Surgical

A number of large investors have recently modified their holdings of ISRG. NorthCrest Asset Manangement LLC raised its position in shares of Intuitive Surgical by 16.0% in the third quarter. NorthCrest Asset Manangement LLC now owns 18,534 shares of the medical equipment provider's stock valued at $7,699,000 after buying an additional 2,558 shares during the last quarter. Woodstock Corp boosted its position in Intuitive Surgical by 4.3% during the third quarter. Woodstock Corp now owns 84,643 shares of the medical equipment provider's stock worth $34,418,000 after acquiring an additional 3,503 shares during the last quarter. JGP Wealth Management LLC boosted its position in Intuitive Surgical by 11.6% during the third quarter. JGP Wealth Management LLC now owns 2,593 shares of the medical equipment provider's stock worth $1,054,000 after acquiring an additional 270 shares during the last quarter. Jacobs & Co. CA grew its stake in Intuitive Surgical by 12.5% in the 3rd quarter. Jacobs & Co. CA now owns 29,299 shares of the medical equipment provider's stock worth $11,913,000 after acquiring an additional 3,256 shares during the period. Finally, Valley Wealth Managers Inc. grew its stake in Intuitive Surgical by 2.4% in the 3rd quarter. Valley Wealth Managers Inc. now owns 4,954 shares of the medical equipment provider's stock worth $2,014,000 after acquiring an additional 115 shares during the period. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical News Summary

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: UBS reiterated a Buy rating and maintained its $500 price target, citing Intuitive Surgical’s long-term robotic surgery growth runway. The target implies meaningful upside from recent trading levels. Intuitive Surgical Buy Rating Reiterated on Long-Term Robotic Growth Runway
• Positive Sentiment: Erste Group Bank raised its FY2027 EPS forecast to $10.09 from $10.06. Although the increase was modest, the estimate remains well above the current-year consensus of $8.87, reinforcing expectations for continued earnings growth.
• Positive Sentiment: A recent comparison with Abbott Laboratories highlighted Intuitive Surgical’s stronger growth profile, including approximately 20% revenue growth, zero debt and significant long-term expansion potential. Those strengths support the premium valuation investors assign to ISRG, though the stock trades at a much higher multiple.
• Neutral Sentiment: Intuitive Surgical is expected to report quarterly earnings on Tuesday. The results and management’s outlook could drive the next significant move, particularly given the stock’s elevated valuation and high investor expectations. Intuitive Surgical Expected to Post Quarterly Earnings
• Negative Sentiment: BTIG lowered its price target to $454 from $469, while retaining a Buy rating. The reduction suggests more limited near-term upside than previously expected and offsets some of the optimism from UBS. Intuitive Surgical Stock Price Target Lowered at BTIG Research

About Intuitive Surgical

Intuitive Surgical, Inc develops and commercializes robotic-assisted systems and related technologies designed to support minimally invasive medical procedures. The company's products are intended to help surgeons perform operations through small incisions while providing enhanced visualization, precision, and control.

Its principal product is the da Vinci Surgical System, a platform used across a range of specialties, including general surgery, urology, gynecology, thoracic surgery, and cardiac procedures.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.